Implementation Science Methodology for the Successful Introduction of High‐Dose Methotrexate for the Treatment of Pediatric Mature B‐Cell Non‐Hodgkin Lymphoma in a Resource‐Limited Setting
The use of implementation science methodology allowed a careful introduction of the use of HD-MTX for the treatment of pediatric MB-NHL in a resource-limited setting.
Authors
- Jacqueline Kamanga
- Hutton Chapman (ORCID: https://orcid.org/0000-0001-5574-8532)
- Heronima Joas Kashaigili (ORCID: https://orcid.org/0000-0002-1295-7921)
- Goodluck Nchasi (ORCID: https://orcid.org/0000-0002-1002-0596)
- Paul S. Ntemi
- Kristin Schroeder
- Richard Mahene
- Dativa Zelama
Institutions
- Catholic University of Health and Allied Sciences (TZ)
- Duke Institute for Health Innovation (US)
- Bugando Medical Centre (TZ)
- Duke University Hospital (US)
Publication Details
- Journal
- Pediatric Blood & Cancer
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1002/1545-5017.70019
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.00